IRCT20200127046282N52
Recruiting
Phase 1
Investigation of the safety and effectiveness of the combined treatment of fractional CO2 laser and exosome derived from adipose tissue mesenchymal stem cells in the treatment of acne scars and skin rejuvenation compared to fractional CO2 laser alone: ??a randomized, single-blind clinical trial
Overview
- Phase
- Phase 1
- Intervention
- Not specified
- Conditions
- Condition 1: Skin aging. Condition 2: Atrophic scar.
- Sponsor
- Tehran University of Medical Sciences
- Enrollment
- 16
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •A patient with moderate and severe acne scars
- •Complete consent of the patient to participate in the plan.
Exclusion Criteria
- •Receiving chemotherapy in the last 5 years
- •Pregnancy or breastfeeding
- •Active wound or infection at the treatment site
- •Receiving any topical or systemic medication in the last 3 months for acne scars
Outcomes
Primary Outcomes
Not specified
Similar Trials
Completed
Not Applicable
The evaluation of the efficacy and the safety of TSUMURA Tokishakuyakusan Extract Granules for Ethical Use on endometriosis patients with dysmenorrheaEndometriosisJPRN-UMIN000017908Tottori University Faculty of Medicine15
Not yet recruiting
Phase 1
Investigating targEting LysyL oxIdase tO ameliorate scarring in burn Traumaburn injurySkin - Other skin conditionsInjuries and Accidents - BurnsACTRN12623001071617university of western australia60
Not yet recruiting
Phase 3
Investigating the effect of conditioning medium in the treatment of alopeciaIRCT20221026056309N1Iran University of Medical Sciences24
Recruiting
Not Applicable
A pilot study on the safety and effectiveness of the Ligation of Intersphincteric Fistula Tract (LIFT) procedure as a treatment for fistula-in-ano.Fistula-in-anoSurgery - Surgical techniquesACTRN12610000669099Dr Peter Lee20
Completed
Not Applicable
Safety and Efficacy of the Adapt Pericardial Patch in the repair of defects associated with congenital heart disease in participants aged between 1 and 12 years of ageCongenital Heart Disease including ventricular septal defect repair, atrial ventricular septal defect, atrio ventricular septal defects as determined by clinical assessment including MRI and echo cardiographyCardiovascular - Other cardiovascular diseasesACTRN12613000308796A/Professor Christian Brizard40